Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Short term Debt: 2016-2018

Historic Short term Debt for Niagen Bioscience (NAGE) over the last 3 years, with Dec 2018 value amounting to $137,000.

  • Niagen Bioscience's Short term Debt fell 55.81% to $137,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $137,000, marking a year-over-year decrease of 55.81%. This contributed to the annual value of $137,000 for FY2018, which is 55.81% down from last year.
  • Niagen Bioscience's Short term Debt amounted to $137,000 in FY2018, which was down 55.81% from $310,000 recorded in FY2017.
  • In the past 5 years, Niagen Bioscience's Short term Debt ranged from a high of $1.5 million in FY2016 and a low of $137,000 during FY2018.
  • In the last 3 years, Niagen Bioscience's Short term Debt had a median value of $327,000 in 2016 and averaged $579,894.
  • Data for Niagen Bioscience's Short term Debt shows a maximum YoY crashed of 77.50% (in 2016) over the last 5 years.
  • Yearly analysis of 3 years shows Niagen Bioscience's Short term Debt stood at $1.5 million in 2016, then plummeted by 77.50% to $344,000 in 2016, then fell by 9.88% to $310,000 in 2017, then crashed by 55.81% to $137,000 in 2018.